相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
Ellen Duong et al.
IMMUNITY (2022)
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Jonas S. Heitmann et al.
NATURE (2022)
Addressing the Cold Reality of mRNA Vaccine Stability
Daan J. A. Crommelin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens
Johnathan Canton et al.
NATURE IMMUNOLOGY (2021)
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy
Jutaek Nam et al.
ADVANCED SCIENCE (2021)
TRAF6-IRF5 kinetics, TRIF, and biophysical factors drive synergistic innate responses to particle-mediated MPLA-CpG co-presentation
P. Pradhan et al.
SCIENCE ADVANCES (2021)
Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells
Kavya Rakhra et al.
SCIENCE IMMUNOLOGY (2021)
A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion
Devin Dersh et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
Geoffrey M. Lynn et al.
NATURE BIOTECHNOLOGY (2020)
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Tyson J. Moyer et al.
NATURE MEDICINE (2020)
Pharmacokinetic tuning of protein-antigen fusions enhances the immunogenicity of T-cell vaccines
Naveen K. Mehta et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines
Daniel Shae et al.
ACS NANO (2020)
Controlling timing and location in vaccines
Darrell J. Irvine et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Cross-presentation of exogenous antigens on MHC I molecules
Jeff D. Colbert et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency
Xiaoyu Hong et al.
SCIENCE ADVANCES (2020)
Immunoribosomes: Where's there's fire, there's fire
Jiajie Wei et al.
MOLECULAR IMMUNOLOGY (2019)
Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies
Aneesh Thakur et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Delivery of Antigen to CD8+ Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity
Chen-Yi Chiang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells
Frances C. Knight et al.
ACS NANO (2019)
Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity
D. Scott Wilson et al.
NATURE MATERIALS (2019)
Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development
Janine K. Tom et al.
TRENDS IN BIOTECHNOLOGY (2019)
The proton sponge hypothesis: Fable or fact?
Lotte M. P. Vermeulen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells
Heng Dong et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy
Bijun Zeng et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy
Rui Kuai et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability
Kelly D. Moynihan et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Current Concepts of Antigen Cross-Presentation
Maria Embgenbroich et al.
FRONTIERS IN IMMUNOLOGY (2018)
Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines
Feng Qiu et al.
BIOMATERIALS (2018)
Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists
Michael A. Collier et al.
MOLECULAR PHARMACEUTICS (2018)
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Nataschja I. Ho et al.
FRONTIERS IN IMMUNOLOGY (2018)
Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
E. Bridie Clemens et al.
VACCINES (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing
Timothy Z. Chang et al.
BIOMATERIALS SCIENCE (2017)
pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response
Qi Liu et al.
ACS NANO (2015)
TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
Burcu Temizoz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens
Andres Alloatti et al.
IMMUNITY (2015)
Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens
Cynthia M. Fehres et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery
Susan N. Thomas et al.
CURRENT OPINION IN CHEMICAL ENGINEERING (2015)
Modulation of Innate Immune Responses via Covalently Linked TLR Agonists
Janine K. Tom et al.
ACS CENTRAL SCIENCE (2015)
Induction of Potent CD8 T Cell Cytotoxicity by Specific Targeting of Antigen to Cross-Presenting Dendritic Cells In Vivo via Murine or Human XCR1
Evelyn Hartung et al.
JOURNAL OF IMMUNOLOGY (2015)
TLR Signals Induce Phagosomal MHC-I Delivery from the Endosomal Recycling Compartment to Allow Cross-Presentation
Priyanka Nair-Gupta et al.
CELL (2014)
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study
Luis J. Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
pH-Responsive Nanoparticle Vaccines for Dual-Delivery of Antigens and Immunostimulatory Oligonucleotides
John T. Wilson et al.
ACS NANO (2013)
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Peter Michael Moyle et al.
CHEMMEDCHEM (2013)
TLR7 Triggering with Polyuridylic Acid Promotes Cross-Presentation in CD8α+ Conventional Dendritic Cells by Enhancing Antigen Preservation and MHC Class I Antigen Permanence on the Dendritic Cell Surface
Maria I. Crespo et al.
JOURNAL OF IMMUNOLOGY (2013)
Cellular immune correlates of protection against symptomatic pandemic influenza
Saranya Sridhar et al.
NATURE MEDICINE (2013)
Micro and Nanoparticle-Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective
Jardin Leleux et al.
ADVANCED HEALTHCARE MATERIALS (2013)
Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro
Tirth R. Ghimire et al.
IMMUNOLOGY LETTERS (2012)
Engineering Approaches to Immunotherapy
Melody A. Swartz et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Cross-presentation by dendritic cells
Olivier P. Joffre et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Improved antigen cross-presentation by polyethyleneimine-based nanoparticles
Jian Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
Type I IFNs Control Antigen Retention and Survival of CD8α+ Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming
Silvia Lorenzi et al.
JOURNAL OF IMMUNOLOGY (2011)
Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
Daniel F. Hoft et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
James J. Moon et al.
NATURE MATERIALS (2011)
Virus-specific CD8 T cells: activation, differentiation and memory formation
Melanie Wiesel et al.
APMIS (2009)
The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement
Irina Caminschi et al.
BLOOD (2008)
In vivo colocalization of antigen and cytidyl guanosyl within dendritic cells is associated with the efficacy of cancer immunotherapy
Stefan Nierkens et al.
CANCER RESEARCH (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Cooperation of Toll-like receptor signals in innate immune defence
Giorgio Trinchieri et al.
NATURE REVIEWS IMMUNOLOGY (2007)
IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens
Caterina Lapenta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
ST Reddy et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio
R Wahid et al.
JOURNAL OF VIROLOGY (2005)
Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity
Y Suzuki et al.
CANCER RESEARCH (2004)
Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I
E Reits et al.
IMMUNITY (2003)
CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo
JMM den Haan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
